Literature DB >> 16043241

Metabotropic glutamate receptor 1 blockade impairs acquisition and retention in a spatial Water maze task.

Thomas Steckler1, Ana F M Oliveira, Chistophe Van Dyck, Hansfried Van Craenendonck, Ana M A Mateus, Xavier Langlois, Anne S J Lesage, Jos Prickaerts.   

Abstract

Metabotropic glutamate receptors, including the mGlu1 receptor, have received considerable attention as potential targets for anxiolytic, antidepressant, antipsychotic and antinociceptive drugs. mGlu1 receptors have also been suggested to play a role in the modulation of cognitive processes, but knowledge is still very limited. In the present study the effects of the selective mGlu1 receptor antagonist 3,4-dihydro-2H-pyrano[2,3]beta-quinolin-7-yl)(cis-4-methoxycyclohexyl)methanone (JNJ16259685, 0.63-10 mg/kg s.c.) on more or less spatially demanding learning and spatial memory (retention and re-acquisition) were investigated in mice performing in a water maze. Selective mGlu1 receptor blockade with JNJ16259685 impaired spatial acquisition processes, irrespective of spatial load, as well as spatial re-acquisition, already at the lowest dose tested (0.63 mg/kg). In contrast, effects on spatial retention performance were relatively mild in mice that had learned to locate the position of the escape platform prior to treatment. Thigmotaxic behaviour and locomotor activity appeared to be unaffected by JNJ16259685. These data suggest that blockade of the mGlu1 receptor primarily affects learning of new information, but leaves retention of spatial information relatively unaffected. Blockade of the mGlu5 receptor with MPEP also impaired spatial learning, although only at the highest dose tested (10 mg/kg). An ex vivo receptor occupancy study in rats revealed that MPEP occupied central mGlu5 receptors with an ED(50) of 2.0 mg/kg one hour after subcutaneous administration. This is 50-150 times higher than the ED(50) reported for JNJ16259685 at central mGlu1 receptors and suggests that one reason why the two compounds cause cognitive effects at different doses might be due to differences in central mGlu receptor occupancy, rather than fundamentally different roles of mGlu1 and mGlu5 receptors in the modulation of cognitive function.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16043241     DOI: 10.1016/j.bbr.2005.05.010

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  27 in total

1.  Two new non-competitive mGlu1 receptor antagonists are potent tools to unravel functions of this mGlu receptor subtype.

Authors:  T Knöpfel
Journal:  Br J Pharmacol       Date:  2007-05-14       Impact factor: 8.739

Review 2.  Metabotropic glutamate receptor ligands as potential therapeutics for addiction.

Authors:  M Foster Olive
Journal:  Curr Drug Abuse Rev       Date:  2009-01

3.  Role of the metabotropic glutamate receptor subtype 1 in the harmaline-induced tremor in rats.

Authors:  Wacław Kolasiewicz; Katarzyna Kuter; Jadwiga Wardas; Krystyna Ossowska
Journal:  J Neural Transm (Vienna)       Date:  2009-06-24       Impact factor: 3.575

4.  Interaction between the mGlu receptors 5 antagonist, MPEP, and amphetamine on memory and motor functions in mice.

Authors:  Francesca Managò; Sebastien Lopez; Alberto Oliverio; Marianne Amalric; Andrea Mele; Elvira De Leonibus
Journal:  Psychopharmacology (Berl)       Date:  2012-11-29       Impact factor: 4.530

Review 5.  Recent advances in the medicinal chemistry of the metabotropic glutamate receptor 1 (mGlu₁).

Authors:  Dafydd R Owen
Journal:  ACS Chem Neurosci       Date:  2011-03-10       Impact factor: 4.418

6.  Effects of group I metabotropic glutamate receptor antagonists on the behavioral sensitization to motor effects of cocaine in rats.

Authors:  Olga A Dravolina; Wojciech Danysz; Anton Y Bespalov
Journal:  Psychopharmacology (Berl)       Date:  2006-06-20       Impact factor: 4.530

7.  Blockade of mGluR1 receptor results in analgesia and disruption of motor and cognitive performances: effects of A-841720, a novel non-competitive mGluR1 receptor antagonist.

Authors:  O El-Kouhen; S G Lehto; J B Pan; R Chang; S J Baker; C Zhong; P R Hollingsworth; J P Mikusa; E A Cronin; K L Chu; S P McGaraughty; M E Uchic; L N Miller; N M Rodell; M Patel; P Bhatia; M Mezler; T Kolasa; G Z Zheng; G B Fox; A O Stewart; M W Decker; R B Moreland; J D Brioni; P Honore
Journal:  Br J Pharmacol       Date:  2006-10-03       Impact factor: 8.739

8.  Regulation of motivation to self-administer ethanol by mGluR5 in alcohol-preferring (P) rats.

Authors:  Joyce Besheer; Sara Faccidomo; Julie J M Grondin; Clyde W Hodge
Journal:  Alcohol Clin Exp Res       Date:  2007-12-21       Impact factor: 3.455

9.  Effects of mGlu1-receptor blockade on ethanol self-administration in inbred alcohol-preferring rats.

Authors:  J Besheer; S Faccidomo; J J M Grondin; C W Hodge
Journal:  Alcohol       Date:  2008-02       Impact factor: 2.405

10.  Allosteric modulators for mGlu receptors.

Authors:  F Gasparini; W Spooren
Journal:  Curr Neuropharmacol       Date:  2007-09       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.